These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35910221)

  • 21. An integrated analysis of
    Huang C; Qiu O; Mao C; Hu Z; Qu S
    Cancer Innov; 2022 Oct; 1(3):240-251. PubMed ID: 38089762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic biomarker HIF1α and its correlation with immune infiltration in gliomas.
    Ding Z; Zhang J; Li L; Wang C; Mei J
    Oncol Lett; 2024 May; 27(5):193. PubMed ID: 38495835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 27. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
    Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
    Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
    J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The overexpression and clinical significance of TBX15 in human gliomas.
    Yan D; Yu Y; Ni Q; Meng Q; Wu H; Ding S; Liu X; Tang C; Liu Q; Yang K
    Sci Rep; 2023 Jun; 13(1):9771. PubMed ID: 37328486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.
    Miftah H; Naji O; Ssi SA; Ghouzlani A; Lakhdar A; Badou A
    Front Immunol; 2023; 14():1139268. PubMed ID: 37575237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas.
    Liu X; Chen F; Li W
    Int Immunopharmacol; 2020 Jun; 83():106400. PubMed ID: 32193105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
    Wang LJ; Lv P; Lou Y
    Front Oncol; 2022; 12():862723. PubMed ID: 35574375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas.
    Zhao M; Li X; Chen Y; Wang S
    Front Oncol; 2022; 12():854598. PubMed ID: 35372062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma.
    Zhou Z; Xu J; Huang N; Tang J; Ma P; Cheng Y
    Front Oncol; 2022; 12():855434. PubMed ID: 35719998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 38. Exploring the significance and potential mechanisms of hippo pathway-associated genes in prognosis of glioma patients.
    Liu X; Fan H; Chen Z; Liu C
    Discov Oncol; 2024 Oct; 15(1):536. PubMed ID: 39382606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma.
    Zhu H; Hu X; Feng S; Li Y; Zhang Y; Qiu S; Chen R; Ye Y; Gu L; Jian Z; Xu X; Xiong X
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
    Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
    Front Genet; 2022; 13():874896. PubMed ID: 35865011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.